Gonorrhea: Difference between revisions
m (Bot: Removing from Primary care) |
|||
(26 intermediate revisions by 8 users not shown) | |||
Line 2: | Line 2: | ||
{{DiseaseDisorder infobox | | {{DiseaseDisorder infobox | | ||
Name = Gonorrhea | | Name = Gonorrhea | | ||
Image = Neisseria gonorrhoeae.jpg | Image = Neisseria gonorrhoeae.jpg - Source: https://www.cdc.gov/| | ||
}} | }} | ||
{{Gonorrhea}} | {{Gonorrhea}} | ||
{{About1|Neisseria gonorrhoeae}} | |||
'''For patient information click [[{{PAGENAME}} (patient information)|here]]''' | '''For patient information click [[{{PAGENAME}} (patient information)|here]]''' | ||
{{CMG}}; | {{CMG}}; {{AE}} {{SaraM}} | ||
{{SK}} Neisseria gonorrhoeae infection; the clap; gonococcemia | {{SK}} Neisseria gonorrhoeae infection; the clap; gonococcemia; gonorrhoea; disseminated gonococcal infection; gonococcal infection; gonococcus infection; Gonococcemia; Gonococcaemia; Gonococcal septicaemia; | ||
Gonococcal septicemia; Systemic gonococcal infection; Complicated systemic gonorrhea | |||
==[[Gonorrhea overview|Overview]]== | ==[[Gonorrhea overview|Overview]]== | ||
Line 32: | Line 29: | ||
==[[Gonorrhea risk factors|Risk Factors]]== | ==[[Gonorrhea risk factors|Risk Factors]]== | ||
==[[Gonorrhea natural history, complications, and prognosis|Natural | ==[[Gonorrhea screening|Screening]]== | ||
==[[Gonorrhea natural history, complications, and prognosis|Natural History, Complications, and Prognosis]]== | |||
== Diagnosis == | == Diagnosis == | ||
[[Gonorrhea history and symptoms|History and Symptoms]] | [[Gonorrhea physical examination|Physical Examination]] | [[Gonorrhea laboratory tests|Lab Tests | [[Gonorrhea history and symptoms|History and Symptoms]] | [[Gonorrhea physical examination|Physical Examination]] | [[Gonorrhea laboratory tests|Lab Tests]] | [[Gonorrhea other diagnostic studies|Other Diagnostic Studies]] | ||
== Treatment == | == Treatment == | ||
[[Gonorrhea medical therapy|Medical Therapy]] | [[Gonorrhea primary prevention|Primary Prevention]] | [[Gonorrhea secondary prevention|Secondary Prevention]] | [[Gonorrhea cost-effectiveness of therapy|Cost-Effectiveness of Therapy]] | [[Gonorrhea future or investigational therapies|Future of Investigational Therapies]] | [[Gonorrhea medical therapy|Medical Therapy]] | [[Gonorrhea Antibiotic Resistance|Antibiotic Resistance]] | [[Gonorrhea primary prevention|Primary Prevention]] | [[Gonorrhea secondary prevention|Secondary Prevention]] | [[Gonorrhea cost-effectiveness of therapy|Cost-Effectiveness of Therapy]] | [[Gonorrhea future or investigational therapies|Future of Investigational Therapies]] | ||
==Case Studies== | |||
[[Gonorrhea case study one|Case #1]] | |||
==External links== | ==External links== | ||
Line 47: | Line 49: | ||
*[http://www.cdc.gov/std/Gonorrhea/default.htm Centers for Disease Control and Prevention: Gonorrhea Information] | *[http://www.cdc.gov/std/Gonorrhea/default.htm Centers for Disease Control and Prevention: Gonorrhea Information] | ||
[[Category:Gynecology]] | |||
[[Category: | |||
Latest revision as of 21:54, 29 July 2020
Template:DiseaseDisorder infobox
Gonorrhea Microchapters |
Diagnosis |
Treatment |
Case Studies |
Gonorrhea On the Web |
American Roentgen Ray Society Images of Gonorrhea |
For patient information click here
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Sara Mehrsefat, M.D. [2]
Synonyms and keywords: Neisseria gonorrhoeae infection; the clap; gonococcemia; gonorrhoea; disseminated gonococcal infection; gonococcal infection; gonococcus infection; Gonococcemia; Gonococcaemia; Gonococcal septicaemia; Gonococcal septicemia; Systemic gonococcal infection; Complicated systemic gonorrhea
Overview
Historical Perspective
Classification
Pathophysiology
Causes
Differentiating Gonorrhea from other Diseases
Epidemiology and Demographics
Risk Factors
Screening
Natural History, Complications, and Prognosis
Diagnosis
History and Symptoms | Physical Examination | Lab Tests | Other Diagnostic Studies
Treatment
Medical Therapy | Antibiotic Resistance | Primary Prevention | Secondary Prevention | Cost-Effectiveness of Therapy | Future of Investigational Therapies